Product
3D1002 + OxyContin
1 clinical trial
1 indication
Indication
Cancer PainClinical trial
A Multicenter, Randomized, Phase IIa/IIb Clinical Trial of 3D1002 Combined With Oxycodone Hydrochloride Sustained-release Tablets in the Treatment of Patients With Moderate to Severe Cancer PainStatus: Not yet recruiting, Estimated PCD: 2025-06-01